한빛사논문 | BRIC

임용택 님의 논문 목록

성균관대학교

CV File 92 kb

Virulence-Free Reconstituted Synthetic Nanopathogen Empowered by Timely-Activating TLR Agonist Promotes Heterologous Cancer Immunotherapy with Depletion of Tumor-Specific Treg Cells
- Adv. Funct. Mater., 03 November 2024 | https://doi.org/10.1002/adfm.202411747
- 2024-11
- 의약학
- 한빛사논문
Transformable Gel-to-Nanovaccine Enhances Cancer Immunotherapy via Metronomic-Like Immunomodulation and Collagen-Mediated Paracortex Delivery
- Adv. Mater., Oct 09 2024, | https://doi.org/10.1002/adma.202409914
- 2024-10
- 바이오·의료융합
- 한빛사논문
Bioconjugated Antibody-Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two-Step Immunomodulation of Myeloid Cells
- Adv. Healthc. Mater., May 21 2024, | https://doi.org/10.1002/adhm.202401270
- 2024-05
- 바이오·의료융합
- 한빛사논문
Nanoengineered Macrophages Armed with TLR7/8 Agonist Enhance Remodeling of Immunosuppressive Tumor Microenvironment
- Small, Nov 15 2023, | https://doi.org/10.1002/smll.202307694
- 2023-11
- 바이오·의료융합
- 한빛사논문
Kinetics reshape antitumor immunity: Timing, duration, and combination are of importance for successful cancer immunotherapy.
- Clin. Transl. Med., Sep 2023, 13 (9) e1420 | https://doi.org/10.1002/ctm2.1420
- 2023-09
- 바이오·의료융합
- 한빛사논문
Molecular Masking of Synthetic Immunomodulator Evokes Antitumor Immunity with Reduced Immune Tolerance and Systemic Toxicity by Temporal Activity Recovery and Sustained Stimulation
- Adv. Mater., Oct 30 2023, | https://doi.org/10.1002/adma.202309039
- 2023-10
- 바이오·의료융합
- 한빛사논문
A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion
- Nat. Nanotechnol., Published: 12 January 2023 | https://doi.org/10.1038/s41565-022-01296-w
- 2023-01
- 바이오·의료융합
- 한빛사논문
Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy
- J. Control. Release, Volume 343, March 2022, Pages 564-583 | https://doi.org/10.1016/j.jconrel.2022.01.047
- 2022-03
- 바이오·의료융합
- 한빛사논문
Overcoming Chemoimmunotherapy-Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
- Adv. Sci., First published: 07 August 2021 | https://doi.org/10.1002/advs.202102043
- 2021-08
- 바이오·의료융합
- 한빛사논문
Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy
- Acc. Chem. Res., Publication Date:September 23, 2020, 53, 10, 2081-2093 | https://doi.org/10.1021/acs.accounts.0c00337
- 2020-09
- 바이오·의료융합
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기